Proportion of telehealth prescriptions climbed across medications
By Lori Solomon HealthDay Reporter
MONDAY, Sept. 16, 2024 (HealthDay News) — Overall prescription volumes for stimulant and antidepressant medications increased from 2019 to 2022, while prescription volume for opioids decreased, according to a study published online Sept. 13 in JAMA Network Open.
Ashwini Nagappan, from University of California, Los Angeles, and colleagues characterized in-person and telehealth prescribing patterns for stimulants, antidepressants, and opioids from 2019 to 2022. The analysis included quarterly medical and pharmacy claims from the Trilliant Health national all-payer claims database for all 50 states and the District of Columbia.
The researchers found that during the study period, prescriptions filled for stimulants increased by 37.5 percent, with the proportion prescribed from a telehealth visit growing from 1.4 percent in 2019 to 38.1 percent in 2022. While in-person stimulant prescribing rebounded from the pandemic, it remained below the pre-public health emergency average of 97.6 percent. Antidepressant prescriptions increased 20.9 percent during the study, with telehealthâs share growing from 1.5 percent to 31.4 percent. Opioid prescriptions declined before quarter 2 of 2020 and continued to decrease by 17.2 percent overall. Most opioid prescriptions were in-person visits, with telehealth prescriptions reaching 24.1 percent in quarter 2 of 2020 and leveling off at 8.4 percent in 2022, an increase from 0 percent in 2019. Women had a higher rate of telehealth prescribing across all drug types. Rural telehealth prescriptions climbed, but their share of the overall telehealth market decreased over time.
“As telehealth policies continue to evolve post-public health emergency, balancing access to prescriptions with mitigating potential risks, such as misuse, is crucial,” the authors write. “Future research should compare telehealth-based and in-person prescribing appropriateness.”
Copyright © 2024 HealthDay. All rights reserved.
